此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Environmental Temperature and White Adipose Tissue in Cancer Patients

2019年7月29日 更新者:Petros Dinas

Effects of Environmental Temperature on White Adipose Tissue Thermogenic Capacity of Cancer Patients

The investigators aimed to retrospectively identify the association between the thermogenic capacity of white adipocytes and the environmental temperature, in cancer patients.

研究概览

地位

完全的

条件

详细说明

Obesity is characterized by excessive white adipose tissue (WAT) that increases risk for disease. About 700 million adults are obese worldwide, designating the need of reducing excessive WAT in humans and subsequently the risk for disease. For this reason, previous research focused on the thermogenic capacity of white adipocytes in response to cold exposure. Cold exposure represents a main stimulus for increased thermogenic capacity in human white adipocytes, which may have an impact on body weight loss and subsequently on obesity phenomenon.

In a cohort of 202 cancer patients (male=126), who undertook a Positron Emission Tomography (PET/CT), we retrospectively investigated the association between Tenv and thermogenic capacity of subcutaneous WAT (dorsolumbar region near vertebrae L3 and abdominal region). These patients undertook a PET/CT examination in order to define their disease status. They were given instructions in advance to refrain from smoking, exercise and excessive muscle stressors 24-hour prior to their examination. On the day of the measurements they advised to transport themselves by car to the PET/CT Laboratory between 08:00 am to 12 pm, following at least a 6-hour fasting. Patients were first injected an appropriate dose of 18F-FDG (based on their body weight) and then they were remained in a sitting relaxed position within a quiet room of 22-24°C for 60 minutes. Following this period, patients undertook the PET/CT examination, which included on average eight bed positions, while four minutes scanning per bed position was used.

PET/CT imaging analysis for WAT activity (dorsolumbar region near vertebrae L3 and abdominal region) was performed by two independent trained physicians, using previous methodology.

研究类型

观察性的

注册 (实际的)

202

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Thessaly
      • Tríkala、Thessaly、希腊、42100
        • Petros Dinas

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Cancer patients independently of their disease status

描述

Inclusion Criteria:

  • Cancer patients who undertook a PET/CT examination independently of their disease status

Exclusion Criteria:

  • Examinations prior to 2016

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Assessment of thermogenic capacity of white adipocytes
大体时间:The SUV of white adipocytes for each patient was measured once via the PET/CT software between 10-30 May 2019.
Thermogenic capacity of white adipocytes was measured via Positron Emission Tomography/computed tomography (PET/CT) device, unit of measurement: Standardized Uptake Value (SUV)
The SUV of white adipocytes for each patient was measured once via the PET/CT software between 10-30 May 2019.
Environmental temperature
大体时间:The daily environmental temperature was obtained from Weather Underground (www.wunderground.com) on the 10th May 2019
The daily environmental temperature was obtained in degrees Celsius for the period 1-1-2016 to 30-4-2019.
The daily environmental temperature was obtained from Weather Underground (www.wunderground.com) on the 10th May 2019

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年5月10日

初级完成 (实际的)

2019年5月31日

研究完成 (实际的)

2019年5月31日

研究注册日期

首次提交

2019年7月25日

首先提交符合 QC 标准的

2019年7月29日

首次发布 (实际的)

2019年7月30日

研究记录更新

最后更新发布 (实际的)

2019年7月30日

上次提交的符合 QC 标准的更新

2019年7月29日

最后验证

2019年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2. Tenv & cancer patient

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅